PROCALAMINE
LOE Approachingamino acids; calcium acetate; glycerin; magnesium acetate; phosphoric acid; potassium chloride; sodium acetate; sodium chloride
NDAINJECTIONINJECTABLE
Approved
May 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PROCALAMINE is a parenteral nutrition formulation containing amino acids, electrolytes, and glycerin for intravenous administration. It provides essential macronutrients and micronutrients to patients unable to meet nutritional requirements orally or enterally. The product supports protein synthesis and metabolic function in critically ill, post-operative, and nutritionally compromised patients.
LOE Approaching
Mature infusion product with moderate competitive pressure (30%) approaching loss of exclusivity; team likely focused on cost management and hospital channel optimization rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PROCALAMINE offers stability in a mature, essential healthcare category with deep hospital relationships, but limited exposure to cutting-edge drug development or commercial launch dynamics. Career progression is strongest in hospital channel expertise, reimbursement negotiation, and operational efficiency rather than innovation or portfolio expansion.
Account Executive (Hospital/IDN)
Worked on PROCALAMINE at B. Braun? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.